Supreme international
Upcoming SlideShare
Loading in...5
×
 

Supreme international

on

  • 195 views

 

Statistics

Views

Total Views
195
Views on SlideShare
195
Embed Views
0

Actions

Likes
0
Downloads
0
Comments
0

0 Embeds 0

No embeds

Accessibility

Categories

Upload Details

Uploaded via as Microsoft PowerPoint

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

Supreme international Supreme international Presentation Transcript

  • SUPREME INTERNATIONAL
  • INTRODUCTION•ESTABLISHED & BASED IN MUMBAI•MANUFACTURERS OF FILTER FABRICS USED INPHARMACEUTICALS, CHEMICALS, DYES, PIGMENTS, MININGCOMPANIES• CAPACITY OF PRODUCING 500000MTRS/DAY•2 WORLD CLASS MANUFACTURING FACILITIES IN THANE.• ABSOLUTE DOMESTIC MARKET LEADER.• BACKED WITH DEALERS NETWORK ALL OVER INDIA• COMPANY’S AVERAGE SALES GROWTH RATE SINCE ITSINCEPTION IS 12.2%
  • ProductsPP Filter FabricsPolyester Filter FabricsNylon Filter FabricsCotton Filter FabricsNON WOVEN Filter Fabrics
  • APPLICATIONSPharmaceuticalsChemicalsDyesPigmentsOil Mills
  • Market Selection Criteria PARAMETERS CHINA SOUTH USA AFRICAMarket Size 5 4 5Market Growth 3 5 3Competitive Intensity High Low HighEntry Barriers Medium Low HighForeign Relations 3 4 5Industry Saturated Developing Developed
  • Market Selection Criteria
  • COUNTRY
  • WHY SOUTH AFRICA Politically stable• Possess well-developed legal, communications, energy, transport, and financial sectors; with a stock exchange that ranks among the 10 largest in the world.• Leading Recipient of FDI• Investment Opportunities are high due to ample resources in terms of land, labour & technology
  • WHY SOUTH AFRICA According to our new research report " South African Healthcare Market Analysis", the pharmaceutical industry in South Africa has been continuously growing despite the concerns of drug inflation. The pharmaceutical industry future remains pleasantly buoyant and it is expected to grow at a CAGR of around 22% during 2010-2013. The optimistic outlook for the industry is based on the fact that private players are making intensive investments. Our Clientile has done huge investments in South Africa.e.g.Cipla Ltd, Lupin Ltd, GSK, Eli & Lilly etc
  • WHY SOUTH AFRICA INCREASING GDP PROJECTS PRONE South Africa led the subregion as foreign direct investment (FDI) inflows into sub-Saharan Africa jumped by 25% in 2011, according to the 2012 World Investment Report by the UN Conference on Trade and Development (Unctad). The report, released in Geneva, Switzerland on Thursday, shows that FDI inflows to sub-Saharan Africa soared from US$29.5-billion in 2010 to $36.9-billion in 2011, a level comparable to the peak of $37.3-billion achieved in 2008, prior to the onset of the global financial crisis. http://www.southafrica.info/business/investing/fdi- 060712.htm#.UIf0Rq5lV8U#ixzz2AE0cereC
  • ENTRY STRATEGYDEALERSHIPS / FRANCHISING1. Will provide marketing & technical know how to the dealers in SA2. Distribute the market among dealers geographically3. Exclusive Dealers only4. Dealers will be the small & local suppliers of filter fabrics to pharma companies5. Commissions based dealership.
  • SEGMENTATION STRATEGY The market will be segmented geographically so that it will be easy for a dealer to supply the products in right time.
  • MARKETINGDifferentiated Marketing will be done to satisfy distinct needs of every customers. Participation in exhibitions.Referrals from Indian subsidies
  • PRICING STRATEGYProducts will be priced reasonably low to penetrate into the marketThe main objective will be to keep new entrants away from the industryIn case of highly innovative product, the premium will be charged.
  • OUR U.S.PQuick After sales Service Technical expertise Low Cost